Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 17/20 | 0.53 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.49 |
| ▸ | BRD4 | O60885 | 1/20 | 0.48 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20512887 | 1.00 | KDM1A (0.53) | KDM1AGPR119BRD4KDM4D | |
| SCHEMBL20512767 | 0.89 | KDM1A (0.70) | KDM1A | |
| SCHEMBL20512896 | 0.88 | KDM1A (0.57) | KDM1AKDM4D | |
| SCHEMBL20512594 | 0.87 | KDM1A (0.59) | KDM1A | |
| SCHEMBL20512904 | 0.86 | KDM1A (0.55) | KDM1A | |
| SCHEMBL20512563 | 0.86 | KDM1A (0.55) | KDM1A | |
| SCHEMBL20512562 | 0.86 | KDM1A (0.55) | KDM1A | |
| SCHEMBL23496011 | 0.85 | KDM1A (0.48) | KDM1AGPR119KDM4D | |
| SCHEMBL20512481 | 0.85 | KDM1A (0.48) | KDM1AGPR119KDM4D | |
| SCHEMBL20512595 | 0.84 | KDM1A (0.75) | KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11510915-B2 | Anti-tumor effect potentiator using novel biphenyl compound | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2022-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11510915-B2 | Anti-tumor effect potentiator using novel biphenyl compound | KDM1B, KDM1A, DOT1L | KDM1A 2/4885GPR119 577/4885BRD4 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.